Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CAMPIGLIO, Manuela")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 8 of 8

  • Page / 1
Export

Selection :

  • and

HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviorsMENARD, Sylvie; BALSARI, Andrea; CASALINI, Patrizia et al.Clinical cancer research. 2002, Vol 8, Num 2, pp 520-525, issn 1078-0432Article

Protein kinase Cα determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplificationMAGNIFICO, Alessandra; ALBANO, Luisa; CAMPANER, Stefano et al.Cancer research (Baltimore). 2007, Vol 67, Num 11, pp 5308-5317, issn 0008-5472, 10 p.Article

Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODNDE CESARE, Michelandrea; SFONDRINI, Lucia; PRATESI, Graziella et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 1, pp 8-15, issn 1524-9557, 8 p.Article

Role of proliferation in HER2 status predicted response to doxorubicinCAMPIGLIO, Manuela; SOMENZI, Giulia; OLGIATI, Clelia et al.International journal of cancer. 2003, Vol 105, Num 4, pp 568-573, issn 0020-7136, 6 p.Article

The HER2 World: Better Treatment Selection for Better OutcomeTAGLIABUE, Elda; CAMPIGLIO, Manuela; PUPA, Serenella M et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 82-85, issn 1052-6773, 4 p.Conference Paper

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective studyCAMPIGLIO, Manuela; BUFALINO, Rosaria; BOTTINI, Alberto et al.Breast cancer research and treatment. 2011, Vol 128, Num 1, pp 147-154, issn 0167-6806, 8 p.Article

Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signalingNORMANNO, Nicola; CAMPIGLIO, Manuela; MAIELLO, Monica R et al.Breast cancer research and treatment. 2008, Vol 112, Num 1, pp 25-33, issn 0167-6806, 9 p.Article

MicroRNA gene expression deregulation in human breast cancerIORIO, Marilena V; FERRACIN, Manuela; MENARD, Sylvie et al.Cancer research (Baltimore). 2005, Vol 65, Num 16, pp 7065-7070, issn 0008-5472, 6 p.Article

  • Page / 1